Detailed explanation of the price and purchasing methods of Zolbetuximab (Vyloy, Zolbetuximab)

Zolbetuximab (Vyloy, Zolbetuximab), as a cutting-edge monoclonal antibody therapy, focuses on attacking the Claudin 18.2 (CLDN18.2) target in gastric cancer and gastroesophageal junction (GEJ) adenocarcinoma. This innovative drug activates the body's immune system to attack tumor cells by precisely binding to the CLDN18.2 protein on the surface of cancer cells, bringing a revolutionary breakthrough in the field of gastric cancer treatment. On March 26, 2024, the successful launch of zotuximab in Japan further proved its important position in cancer treatment.

In terms of price, zotuximab has a relatively high market price due to its unique efficacy and scarcity. According to the latest market information, the price of a box of zotuximab (specific specifications may vary depending on the region) is roughly between 16,000 and 7,000 yuan. However, the actual purchase price may fluctuate depending on the strength of the drug, the region where it is purchased, and the channel through which it is purchased.

For domestic patients eager to obtain zotuximab treatment, although the drug has not yet been officially launched in the domestic market, there are still legal ways to obtain it. Patients can consult professional overseas medical service institutions. These institutions usually have direct cooperative relationships with foreign pharmacies or pharmaceutical companies and can provide a full range of services from drug consultation and purchase to direct delivery to their homes. These institutions not only ensure the formality and safety of drug sources, but also provide professional after-sales services to help patients solve various problems they may encounter during use, thereby improving patients' overall treatment experience.

In summary, zotuximab, as an innovative achievement in the treatment of gastric cancer, provides patients with new treatment hope. Although it is expensive, domestic patients still have the opportunity to obtain this cutting-edge drug through professional overseas medical service institutions and thus benefit from its excellent therapeutic effects.